|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product Revenue, Net | |||||
| License Agreement Revenue | |||||
| Total revenue | |||||
| Operating expenses: | |||||
| Cost of product revenue | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other expense (income): | |||||
| Amortization of debt issuance costs and discount | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income | |||||
| Warrant liability fair value adjustment | |||||
| Derivative liability fair value adjustment | |||||
| Total other income | |||||
| Loss before taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Net loss per share - basic | |||||
| Net loss per share - diluted | |||||
| Weighted average common shares outstanding - basic | |||||
| Weighted average common shares outstanding - diluted | |||||
Loading...